Medical AI Alliance
← Company Index
Medical DevicesKONEX 23325012 approvals

Median Diagnostics Inc.

Official website

Founded in 1999 and listed on KONEX in 2017, Median Diagnostics develops and manufactures immunoassay, molecular, and point-of-care in vitro diagnostic kits for animal diseases.

As of 2026-10-10, Median Diagnostics Inc. has 12 Korean MFDS device approvals, 12 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Median Diagnostics Inc. was founded in 1999 and listed on the KONEX market in 2017, specializing in in vitro diagnostics (IVD) for animal diseases. The company develops, manufactures, and sells animal diagnostic kits for cattle, swine, and poultry along with Biologicals raw materials, using immunoassay (ELISA), molecular diagnostics (PCR, Real-time RT-PCR, DNA Chip), and point-of-care testing (POCT, Rapid Kit) technologies, including products such as the VDRG BVDV Ag Rapid Kit. In fiscal 2025, revenue reached KRW 11,969 million, with ELISA immunoassay kits accounting for about 42.8% and PCR molecular diagnostics for about 27.3%.

Products & technology

  • ELISA for Bovine/Swine/PoultryEnzyme immunoassay-based diagnosis for cattle, swine, poultry
  • PCR & RT-PCR kit / Real-time RT-PCR kitGene amplification diagnostics for animals and humans
  • DNA Chip kitMolecular diagnostics
  • Companion Animals / Livestock & Poultry Rapid kitRapid point-of-care testing for companion animals, livestock, poultry
  • Covid19 ab/ag Rapid kitRapid antigen/antibody testing for humans
  • VDRG BVDV Ag Rapid KitRapid antigen diagnosis of bovine viral diarrhea (BVDV)
  • Bovine pregnancy diagnosis kitDiagnosis of bovine pregnancy

Regulatory approvals

data.go.kr

12 Korean MFDS device approvals · 2020–2024

  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2024-04-01
    Product approval · Class 3체외 제허 24-225 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2022-04-12
    Product approval · Class 3체외 제허 22-240 호
  • MFDSIVD reagent for infectious disease, immunological method2022-02-15
    Product approval · Class 3체외 제허 22-105 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2020-11-12
    Product approval · Class 3체외 제허 20-960 호
  • MFDSSpecimen transport mediaRevoked2020-08-24
    Product approval · Class 1체외 제신 20-1269 호
  • MFDSSpecimen transport mediaRevoked2020-08-13
    Product approval · Class 1체외 제신 20-1217 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-07-16
    Product approval · Class 3체외 제허 20-580 호
  • MFDSIVD reagents for extracting nucleic acidsRevoked2020-06-01
    Product approval · Class 1체외 제신 20-740 호
  • MFDSSpecimen transport mediaRevoked2020-05-20
    Product approval · Class 1체외 제신 20-685 호
  • MFDSTool for specimensRevoked2020-05-08
    Product approval · Class 1제신 20-616 호
  • MFDSTool for specimensRevoked2020-05-08
    Product approval · Class 1제신 20-615 호
  • MFDSIVD reagents for extracting nucleic acidsRevoked2020-05-04
    Product approval · Class 1제신 20-596 호

R&D and key agreements

Source: DART corporate disclosure

ASFV DIVA 백신 개발 · 아프리카돼지열병(ASFV) · New vaccine development pursued

반려동물 암 12종 다중 qPCR 키트 개발 · 반려동물 암 12종 · Multiplex qPCR-based cancer diagnostic kit development

유전자 가위 기반 POCT 진단키트 개발 · Gene-editing-based point-of-care testing kit development

Publications

PubMed · affiliation-matched
Show 2 more publications

Patents

KIPRIS · applicant-matched
Show 53 more patents

AI reads

MAA server logs · IP-verified
53
Times AI engines pulled Median Diagnostics Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

53
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

6
live 0
Last 7 days
37
live 0
Last 30 days
53
live 0
All time
  • OpenAIOAI-SearchBot33
  • GoogleGoogleOther9
  • PerplexityPerplexityBot8
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 7, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Median Diagnostics Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

PCL. Inc6 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

SD BIOSENSOR INC.6 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Boditech Med Inc.5 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

OSANG HEALTHCARE CO.,LTD.5 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

RollingStone Co., Ltd.5 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

HLB PANAGENE Co., LTD.5 shared

Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.

Access Bio, Inc.5 shared

Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.

GC Medical Science Corporation5 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

CALTH. Inc5 shared

Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.

HUMASIS CO., LTD.4 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

Precision Biosensor Inc.4 shared

KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.

Sugentech, Inc.4 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition